The ideal partner for individual storage and materials handling solutions

More space for infusion therapy and clinical nutrition products – New high-bay warehouse for Fresenius Kabi

The existing high-bay warehouse of Fresenius Kabi Deutschland at the Friedberg production site is being expanded by two automated sections. The units will be interconnected in future.

Neuenstadt/Bad Homburg – Fresenius Kabi Deutschland GmbH, one of Germany’s leading companies in the field of infusion therapy and clinical nutrition, is expanding its existing high-bay warehouse at its production site in Friedberg by two further automated sections. All three high-bay sections will be interconnected in future. The storage and retrieval machines and conveyor systems are provided by MLOG Logistics GmbH, Neuenstadt.





One of the tasks of Fresenius Kabi Deutschland GmbH is to provide therapy and care for chronically ill in-patients and out-patients. The company is now constructing a new warehouse with 39,700 storage spaces for infusion therapy and clinical nutrition products in order to optimise capacities at its production site in Friedberg. The expansion will create 75,000 automated pallet spaces.

MLOG is installing nine MSINGLE B-1000/32-ZT storage and retrieval machines. They carry a maximum load of 1,000kg each and are equipped with telescopic forks for double deep storage. The specialist company from Neuenstadt will also install the entire pallet conveyor system at the existing facilities. The company produces all components itself in Neuenberg am Kocher and has successfully used these in numerous previous projects in the pharmaceutical industry. MLOG was commissioned to supply and install the components in May 2010.

About Fresenius Kabi

Fresenius Kabi Deutschland GmbH is one of Germany’s leading companies in the field of infusion therapy and clinical nutrition. Fresenius Kabi Deutschland is a subsidiary of the Fresenius Kabi AG, an international group. One of its main tasks is to provide therapy and care for seriously and chronically ill patients. Fresenius Kabi is a market leader for infusion therapy and clinical nutrition in Europe as well as Latin America and Asia-Pacific, its most important regions. It is one of the leaders in the US market for intravenously administered generic medicines. On 31 March 2010, Fresenius Kabi employed 22,227 people globally.

Contact

Please do not hesitate to contact us if you need further information:


 

 
OK